| scholarly article | Q13442814 |
| P2093 | author name string | Amy S Major | |
| Ashley J Wilhelm | |||
| Jillian P Rhoads | |||
| Nekeithia S Wade | |||
| P2860 | cites work | Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 |
| Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu | Q24625814 | ||
| Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus | Q28591255 | ||
| Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice | Q30432644 | ||
| Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions | Q33294845 | ||
| T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells | Q33842929 | ||
| Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus | Q33923351 | ||
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
| Autoimmunity in atherosclerosis. The role of autoantigens | Q33976585 | ||
| Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus | Q34343906 | ||
| CD40-CD40L interactions in atherosclerosis | Q34498144 | ||
| The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice | Q34821636 | ||
| Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation | Q34936014 | ||
| Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
| Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice | Q35835882 | ||
| Statins induce the accumulation of regulatory T cells in atherosclerotic plaque | Q36071708 | ||
| Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs. | Q36497238 | ||
| Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis | Q36638113 | ||
| Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis | Q36691050 | ||
| IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice | Q36745302 | ||
| ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes | Q36921978 | ||
| Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice | Q37143021 | ||
| The role of adaptive T cell immunity in atherosclerosis | Q37339539 | ||
| Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis | Q37377439 | ||
| The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 | ||
| Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? | Q37454041 | ||
| Inhibition of arterial lesion progression in CD16-deficient mice: evidence for altered immunity and the role of IL-10. | Q37467868 | ||
| Accelerated atherosclerosis in SLE: mechanisms and prevention approaches | Q37658524 | ||
| Adaptive T cell immune responses and atherogenesis | Q37703844 | ||
| Human FoxP3+ regulatory T cells in systemic autoimmune diseases | Q37881234 | ||
| Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain | Q40941667 | ||
| Stability of the regulatory T cell lineage in vivo. | Q42060265 | ||
| A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice | Q42856694 | ||
| The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
| Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 | ||
| Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. | Q43794492 | ||
| Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet | Q46129274 | ||
| Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus | Q46521582 | ||
| Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells | Q46686118 | ||
| A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance. | Q47757213 | ||
| Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus | Q47958022 | ||
| Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE). | Q50864077 | ||
| Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells. | Q52891939 | ||
| Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. | Q53883439 | ||
| Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. | Q54375886 | ||
| Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. | Q54444518 | ||
| Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. | Q54537170 | ||
| Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. | Q54621895 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 | ||
| Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 | ||
| Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells | Q78109916 | ||
| Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells | Q80800895 | ||
| MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus | Q81629357 | ||
| Lupus Atherosclerosis Prevention Study (LAPS) | Q82991610 | ||
| Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis | Q83226583 | ||
| The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice | Q84738724 | ||
| Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus | Q84948994 | ||
| Interleukin-33 augments Treg cell levels: a flaw mechanism in atherosclerosis | Q85566850 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 778-785 | |
| P577 | publication date | 2014-01-06 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice | |
| P478 | volume | 74 |
| Q26744624 | Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression |
| Q39216733 | Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis |
| Q64121750 | Inhibition of IL-17 ameliorates systemic lupus erythematosus in Roquin mice through regulating the balance of TFH cells, GC B cells, Treg and Breg |
| Q92876890 | LCK inhibitor attenuates atherosclerosis in ApoE-/- mice via regulating T cell differentiation and reverse cholesterol transport |
| Q36479452 | Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance Induction. |
| Q60950193 | The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus |
| Q40097536 | The regulation of regulation: IL-10 increases CD4(+) CD25(+) regulatory T cells but impairs their immunosuppressive activity in murine models with schistosomiasis japonica or asthma. |
Search more.